StockWatch
·
Surgical & Medical Instruments & Apparatus
SplitJun 17, 2026, 04:37 PM

Allurion Implements 1-for-15 Reverse Stock Split to Aid Re-listing

AI Summary

Allurion Technologies, Inc. announced a 1-for-15 reverse stock split, effective June 18, 2026, to support regaining compliance with NYSE listing requirements. This action will reduce the number of outstanding shares from approximately 15 million to 1 million. Trading will begin on a split-adjusted basis under the temporary symbol "ALURD" for 20 days before reverting to "ALUR", with proportional adjustments made to all equity instruments.

Key Highlights

  • Allurion Technologies announced a 1-for-15 reverse stock split, effective June 18, 2026.
  • The split aims to regain compliance with NYSE or NYSE American listing requirements.
  • Outstanding shares will decrease from approximately 15,006,253 to 1,000,417.
  • Trading will commence on a split-adjusted basis under temporary symbol "ALURD" for 20 days.
  • The trading symbol will revert to "ALUR" after 20 days, with a new CUSIP 02008G 300.
  • Fractional shares will be rounded up to the next whole share.
  • Equity incentive plans, options, convertible notes, and warrants will be proportionally adjusted.
  • Public warrants (ALUR WS) will be exercisable for 0.00378787 shares at $3,037.50 per share.